StandardAero, Inc. ("StandardAero") announced today that it has launched its proposed initial public offering of its common stock. The proposed offering consists of 46,500,000 shares of common stock.

The Company has granted the underwriters an option, exercisable within 45 days from the closing date of the Offering, to purchase up to an additional 300,000 Ordinary Shares at the initial public offering price, less underwriting discounts, to cover over-allotments, if any.

The Company has granted to the underwriters a 45-day option to purchase up to an additional 232,500 shares of common stock at the public offering price of $4.00 per share, less underwriting discounts and commissions.

MBX Biosciences, Inc. (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the

Guardian Pharmacy Services, Inc. ("Guardian") today announced the launch of its underwritten initial public offering of 6,750,000 shares of its Class A common stock pursuant to a registration statement filed with the U.

YHN Acquisition I Limited (the “Company”) announced today the closing of its initial public offering of 6,000,000 units at $10.00 per

BKV Corporation (“BKV”) today announced that it has launched the initial public offering of 15,000,000 shares of its common stock. The underwriters will have a 30-day option to purchase an additional 2,